‘Overwhelming Efficacy’ Found in New Lung Cancer Drug – Yale PhD Calls it ‘Transformative’
Clinical trials of a new lung cancer treatment has showed unprecedented results in decreasing the risk of death or recurrence from the disease by 89%. After embarking on phase three trials, the drug Tagrisso’s early results yielded such “overwhelming efficacy”…